Roger N. Hayes
Plus aucun poste en cours
Profil
Roger N.
Hayes worked as a Senior Vice President-DMPK at MPI Research, Inc. and as President-Bioanalytical Operations at CRS Management, Inc. He holds a doctorate degree from the University of Adelaide.
Anciens postes connus de Roger N. Hayes
| Sociétés | Poste | Fin |
|---|---|---|
CRS Management, Inc.
 CRS Management, Inc. Miscellaneous Commercial ServicesCommercial Services Cetero Research is an industry leading contract research organization (CRO) in early phase research services. With more than 25 years of experience from its founding companies, Cetero has conducted more than 10,000 clinical pharmacology studies – more than any other CRO. Cetero’s proven track record allows the company to provide flexible and high quality drug development services, and its time-tested systems produce consistent and reliable data Cetero’s clients can trust. Cetero’s clinical research expertise consists of traditional early-stage, healthy-volunteer clinical pharmacology and bioavailability studies, as well as specialty Phase Ia/b trials in patients. Its bioanalytical services support clinical, preclinical drug and biomarker analysis for small and large molecules. In addition, Cetero owns and operates a full-scale central laboratory supporting Phase I-IV clinical trials in North and South America. | Corporate Officer/Principal | 26/06/2012 |
MPI Research, Inc.
 MPI Research, Inc. Miscellaneous Commercial ServicesCommercial Services MPI Research, Inc. provides preclinical research and development services. It offers drug safety, discovery sciences, bio-analytical and analytical solutions, surgical services, medical device evaluation, and specialty services. The company was founded by William U. Parfet in 1995 and is headquartered in Mattawan, MI. | Corporate Officer/Principal | - |
Formation de Roger N. Hayes
| University of Adelaide | Doctorate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
CRS Management, Inc.
CRS Management, Inc. Miscellaneous Commercial ServicesCommercial Services Cetero Research is an industry leading contract research organization (CRO) in early phase research services. With more than 25 years of experience from its founding companies, Cetero has conducted more than 10,000 clinical pharmacology studies – more than any other CRO. Cetero’s proven track record allows the company to provide flexible and high quality drug development services, and its time-tested systems produce consistent and reliable data Cetero’s clients can trust. Cetero’s clinical research expertise consists of traditional early-stage, healthy-volunteer clinical pharmacology and bioavailability studies, as well as specialty Phase Ia/b trials in patients. Its bioanalytical services support clinical, preclinical drug and biomarker analysis for small and large molecules. In addition, Cetero owns and operates a full-scale central laboratory supporting Phase I-IV clinical trials in North and South America. | Commercial Services |
MPI Research, Inc.
MPI Research, Inc. Miscellaneous Commercial ServicesCommercial Services MPI Research, Inc. provides preclinical research and development services. It offers drug safety, discovery sciences, bio-analytical and analytical solutions, surgical services, medical device evaluation, and specialty services. The company was founded by William U. Parfet in 1995 and is headquartered in Mattawan, MI. | Commercial Services |
